Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A

by Kathryn T. Whelan, Ansar A. Pathan, Clare R. Sander, Helen A. Fletcher, Ian Poulton, Nicola C. Alder, Adrian V. S. Hill, Helen McShane
Published 2011-01-01

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.

by Kathryn T Whelan, Ansar A Pathan, Clare R Sander, Helen A Fletcher, Ian Poulton, Nicola C Alder, Adrian V S Hill, Helen McShane
Published 2009-06-01

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.

by Kathryn T. Whelan, Ansar A. Pathan, Clare R. Sander, Helen A. Fletcher, Ian Poulton, Nicola C. Alder, Adrian V. S. Hill, Helen McShane
Published 2011-01-01

Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials

by Ansar A. Pathan, Clare R. Sander, Helen A. Fletcher, Ian Poulton, Nicola C. Alder, Natalie E. R. Beveridge, Kathryn T. Whelan, Adrian V. S. Hill, Helen McShane
Published 2011-01-01

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.

by Ansar A Pathan, Clare R Sander, Helen A Fletcher, Ian Poulton, Nicola C Alder, Natalie E R Beveridge, Kathryn T Whelan, Adrian V S Hill, Helen McShane
Published 2007-10-01

Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials.

by Ansar A. Pathan, Clare R. Sander, Helen A. Fletcher, Ian Poulton, Nicola C. Alder, Natalie E. R. Beveridge, Kathryn T. Whelan, Adrian V. S. Hill, Helen McShane
Published 2011-01-01

Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial

by Andrew Protheroe, Pedro J Romero, Richard Bryant, Lucy Carter, Julianne Hollidge, Ian Poulton, Megan Baker, Celia Mitton, Andrea Baines, Armin Meier, Richard Harrop, Ruth MacPherson, Steven Kennish, Susan Morgan, Selena Vigano, James Catto, Adrian V S Hill
Published 2020-06-01

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine

by Pedro M. Folegatti, Duncan Bellamy, Rachel Roberts, Jonathan Powlson, Nick J. Edwards, Catherine F. Mair, Georgina Bowyer, Ian Poulton, Celia H. Mitton, Nicky Green, Eleanor Berrie, Alison M. Lawrie, Adrian V.S. Hill, Katie J. Ewer, John Hermon-Taylor, Sarah C. Gilbert
Published 2019-05-01

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line

by Pedro M. Folegatti, Duncan Bellamy, Amy Flaxman, Catherine Mair, Chris Ellis, Raquel L. Ramon, Fernando Ramos Lopez, Celia Mitton, Megan Baker, Ian Poulton, Alison Lawrie, Rachel Roberts, Angela Minassian, Katie J. Ewer, Thomas G. Evans, Adrian V. S. Hill, Sarah C. Gilbert
Published 2019-03-01

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies

by Pedro M. Folegatti, Amy Flaxman, Daniel Jenkin, Rebecca Makinson, Lucy Kingham-Page, Duncan Bellamy, Fernando Ramos Lopez, Jonathan Sheridan, Ian Poulton, Jeremy Aboagye, Nguyen Tran, Celia Mitton, Rachel Roberts, Alison M. Lawrie, Adrian V. S. Hill, Katie J. Ewer, Sarah Gilbert
Published 2021-03-01

Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial

by Fiona M. Thompson, David W. Porter, Shinji L. Okitsu, Nicole Westerfeld, Denise Vogel, Stephen Todryk, Ian Poulton, Simon Correa, Claire Hutchings, Tamara Berthoud, Susanna Dunachie, Laura Andrews, Jack L. Williams, Robert Sinden, Sarah C. Gilbert, Gerd Pluschke, Rinaldo Zurbriggen, Adrian V. S. Hill
Published 2011-01-01

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.

by Fiona M Thompson, David W Porter, Shinji L Okitsu, Nicole Westerfeld, Denise Vogel, Stephen Todryk, Ian Poulton, Simon Correa, Claire Hutchings, Tamara Berthoud, Susanna Dunachie, Laura Andrews, Jack L Williams, Robert Sinden, Sarah C Gilbert, Gerd Pluschke, Rinaldo Zurbriggen, Adrian V S Hill
Published 2008-01-01

Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial.

by Fiona M. Thompson, David W. Porter, Shinji L. Okitsu, Nicole Westerfeld, Denise Vogel, Stephen Todryk, Ian Poulton, Simon Correa, Claire Hutchings, Tamara Berthoud, Susanna Dunachie, Laura Andrews, Jack L. Williams, Robert Sinden, Sarah C. Gilbert, Gerd Pluschke, Rinaldo Zurbriggen, Adrian V. S. Hill
Published 2011-01-01

A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial

by Pedro M. Folegatti, Kate Harrison, Lorena Preciado-Llanes, Fernando Ramos Lopez, Mustapha Bittaye, Young Chan Kim, Amy Flaxman, Duncan Bellamy, Rebecca Makinson, Jonathan Sheridan, Sasha R. Azar, Rafael Kroon Campos, Mark Tilley, Nguyen Tran, Daniel Jenkin, Ian Poulton, Alison Lawrie, Rachel Roberts, Eleanor Berrie, Shannan L. Rossi, Adrian Hill, Katie J. Ewer, Arturo Reyes-Sandoval
Published 2021-07-01